Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,600
Closed -$1.15M 93
2026
Q1
$1.15M Buy
9,600
+2,500
+35% +$289K 0.05% 55
2025
Q4
$747K Buy
7,100
+6,400
+914% +$601K 0.04% 53
2025
Q3
$58.8K Buy
+700
New +$57.7K 0.01% 108
2023
Q1
Sell
-5,700
Closed -$632K 112
2022
Q4
$632K Sell
5,700
-41,700
-88% -$4.26M 0.07% 32
2022
Q3
$4.08M Sell
47,400
-3,700
-7% -$330K 0.33% 44
2022
Q2
$4.66M Sell
51,100
-42,300
-45% -$3.75M 0.34% 34
2022
Q1
$7.66M Buy
+93,400
New +$7.36M 0.29% 64
2021
Q4
Sell
-47,000
Closed -$3.53M 203
2021
Q3
$3.53M Buy
47,000
+43,600
+1,282% +$3.32M 0.23% 52
2021
Q2
$264K Sell
3,400
-4,774
-58% -$355K 0.03% 222
2021
Q1
$601K Buy
8,174
+3,668
+81% +$271K 0.05% 34
2020
Q4
$350K Buy
+4,506
New +$345K 0.03% 31

Other funds holding MRK

QVR's MRK Position: Q2 2026 in Review

QVR sold out of Merck (MRK) in Q2 2026, closing a stake of 13,715 shares — an estimated $1.65M sold.

QVR first reported a position in MRK in Q4 2020 and held it in 6 quarters. The position peaked at $2.49M in Q4 2025. 711 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • QVR reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • QVR sold 13,715 Merck shares in Q2 2026, an estimated $1.65M.
  • QVR first reported a position in Merck in Q4 2020 and held it in 6 quarters.
  • QVR's Merck position peaked at $2.49M in Q4 2025.
  • 711 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on QVR's 13F filing for Q2 2026.